The earnings call reveals disappointing financial results with a significant EPS guidance cut, increased medical cost trends, and operating cash outflow. Despite optimistic guidance for 2026, uncertainties in Medicaid margins, high utilization costs, and unclear management responses in the Q&A session raise concerns. The revised guidance and potential negative dynamics overshadow the positive outlook, leading to a negative sentiment prediction.
